Symptomatic local recurrence of prostate carcinoma after radiation therapy

Cancer

Volumn 103, Issue 10, 2005, Pages 2060-2066

  Leibovici, Dan ^a   Lee, Andrew K ^a   Cheung, Rex M ^a   Spiess, Philippe E ^a   Kuban, Deborah A ^a   Rosser, Charles J ^a,b   Shen, Yu ^a   Yang, Ying ^a   Chichakli, Ramsey ^a   Pisters, Louis L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Local control; Palliation; Radiation; Symptomatic

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; BLOOD LEVEL; CANCER RADIOTHERAPY; CANCER RECURRENCE; FOLLOW UP; GLEASON SCORE; HEMATURIA; HISTOLOGY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MICTURITION DISORDER; PRIORITY JOURNAL; PROSTATE CARCINOMA; REVIEW; RISK FACTOR; TUMOR CLASSIFICATION; URINARY TRACT OBSTRUCTION;

AGED; AGED, 80 AND OVER; CARCINOMA; CAUSE OF DEATH; COHORT STUDIES; FOLLOW-UP STUDIES; FORECASTING; HEMATURIA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PELVIC PAIN; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RETROSPECTIVE STUDIES; RISK FACTORS; URETHRAL OBSTRUCTION; URINARY BLADDER NECK OBSTRUCTION; URINATION DISORDERS;

EID: 18044381511     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20990     Document Type: Review

References (17)

1. Roach M, Lu J, Pilepich MV, et al. Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on Radiation Therapy Oncology Group clinical trials. Int J Radiat Oncol Biol Phys. 2000;47:609-615.
2. Grossfeld JD, Yu-Ping L, Lubeck DP, Carroll PR. Patterns of failure after primary local therapy for prostate cancer and rationale for secondary therapy. Urology. 2002;(S)3A:57-63.
3. Johansson JE, Holmberg L, Johansson S, Bergstrom R, Adami HO. Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA. 1997;277:467-471.
4. Hanks GE, Hanlon AL, Epstein B, Horwitz EM. Dose response in prostate cancer with 8-12 years' follow-up. Int J Radiat Oncol Biol Phys. 2002;54:427-435.
5. Sylvester JE, Blasko JC, Grimm PD, Meier R, Malmgren JA. Ten-year biochemical relapse free survival after external beam radiation and brachytherapy for localized prostate cancer: the Seattle experience. Int J Radiat Oncol Biol Phys. 2003;57:944-952.
6. Kuban DA, Thames HD, Levy LB, et al. Long-term multi-institutional analysis of Stage T1-T2 prostate cancer treated with radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys. 2003;57:915-928.
7. Kneebone A, Turner S, Berry M, Cakir B, Gebski V. Australian prostate specific antigen outcome and toxicity following radiation therapy for localized prostate cancer. Australas Radiol. 2003;47:422-427.
8. Cox JD, Grignon DJ, Kaplan RS, Parsons JT, Schellhammer PF. American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus statement: guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys. 1997;37:1035-1041.
9. Almroth A, Ljung G, Eklund T, et al. Value of sextant biopsies in the assessment of local cure following external beam radiotherapy of prostatic adenocarcinoma. Scand J Urol Nephrol. 1998;32:111-115.
10. Hanks GE, Krall JM, Martz KL, Diamond JJ, Kramer S. The outcome of treatment of 313 patients with T-1 (UICC) prostate cancer treated with external beam irradiation. Int J Radiat Oncol Biol Phys. 1988;14:243-248.
11. Freiha FS, Bagshaw MA. Carcinoma of the prostate: results of post-irradiation biopsy. Prostate. 1984;5:19-25.
12. Roach M, Lu J, Pilepich MV, et al. Long-term survival after radiotherapy alone: Radiation Therapy Oncology Group prostate cancer trials. J Urol. 1999;161:864-868.
13. Rosser CJ, Levy LB, Kuban DA, et al. Hazard rates for disease progression after external beam radiotherapy for clinically localized carcinoma of the prostate. J Urol. 2003;169:2160-2165.
14. Zietman AL, Chung CS, Coen JJ, Shipley WU. Ten-year outcome for men with localize prostate cancer treated with external radiation therapy: results of a cohort study. J Urol. 2004;171:210-214.
15. Maartense S, Hermans J, Leer WH. Radiation therapy in localized prostate cancer: long-term results and toxicity. Clin Oncol. 2000;12:222-228.
16. al-Abany M, Helgason AR, Cronqvist AKA, Svensson C, Wersall P, Steineck G. Long-term symptoms after external beam radiation therapy for prostate cancer with three or four fields. Acta Oncol. 2002;41:532-542.
17. Sandhu AS, Zelefsky MJ, Lee HJ, Lombardi D, Fuks Z, Leibel SA. Long-term urinary toxicity after 3-dimensional conformal radiotherapy for prostate cancer in patients with prior history of transurethral resection. Int J Radiat Oncol Biol Phys. 2000;48:643-647.